Barclays PLC Lifevantage Corp Transaction History

Barclays PLC

$854 Billion
Q3 2025

A detailed history of Barclays PLC transactions in Lifevantage Corp stock. As of the latest transaction made, Barclays PLC holds 35,368 shares of LFVN stock, worth $233,782. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,368

Previous 30,674 15.3%

Holding current value

$233,782

Previous $401,000 14.21%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$9.73 - $14.51 $45,672 - $68,109	4,694 Added 15.3%	35,368 $344,000
Q2 2025 Aug 13, 2025	BUY	$11.18 - $16.05 $34,143 - $49,016	3,054 Added 11.06%	30,674 $401,000
Q1 2025 May 15, 2025	SELL	$14.42 - $25.62 $228,585 - $406,128	-15,852 Reduced 36.46%	27,620 $402,000
Q4 2024 Feb 13, 2025	BUY	$11.34 - $17.85 $17,078 - $26,882	1,506 Added 3.59%	43,472 $763,000
Q3 2024 Nov 15, 2024	BUY	$5.51 - $13.01 $63,960 - $151,020	11,608 Added 38.24%	41,966 $507,000

Q3 2022 Nov 03, 2022	SELL	$3.48 - $4.51 $5,755 - $7,459	-1,654 Reduced 5.17%	30,358 $114,000
Q2 2022 Aug 12, 2022	SELL	$3.82 - $4.89 $2,842 - $3,638	-744 Reduced 2.27%	32,012 $139,000
Q4 2021 Feb 14, 2022	SELL	$6.15 - $7.68 $10,510 - $13,125	-1,709 Reduced 4.96%	32,756 $207,000
Q3 2021 Nov 09, 2021	SELL	$6.5 - $8.38 $22,698 - $29,262	-3,492 Reduced 9.2%	34,465 $234,000
Q2 2021 Aug 13, 2021	BUY	$6.9 - $9.59 $98,725 - $137,213	14,308 Added 60.5%	37,957 $279,000
Q1 2021 May 13, 2021	BUY	$8.58 - $10.21 $164,959 - $196,297	19,226 Added 434.68%	23,649 $221,000
Q4 2020 Feb 11, 2021	SELL	$9.32 - $13.4 $16,729 - $24,053	-1,795 Reduced 28.87%	4,423 $42,000
Q3 2020 Nov 12, 2020	SELL	$12.07 - $15.31 $15,099 - $19,152	-1,251 Reduced 16.75%	6,218 $75,000
Q2 2020 Aug 12, 2020	BUY	$10.25 - $16.54 $27,285 - $44,029	2,662 Added 55.38%	7,469 $101,000
Q1 2020 May 13, 2020	SELL	$7.91 - $16.96 $73,911 - $158,474	-9,344 Reduced 66.03%	4,807 $50,000
Q4 2019 Feb 10, 2020	BUY	$13.48 - $15.86 $97,514 - $114,731	7,234 Added 104.58%	14,151 $221,000
Q3 2019 Nov 14, 2019	SELL	$10.8 - $14.6 $51,494 - $69,612	-4,768 Reduced 40.8%	6,917 $95,000
Q2 2019 Aug 14, 2019	SELL	$10.68 - $14.55 $808,999 - $1.1 Million	-75,749 Reduced 86.64%	11,685 $152,000
Q1 2019 May 15, 2019	BUY	$12.54 - $16.12 $328,974 - $422,892	26,234 Added 42.87%	87,434 $1.25 Million
Q4 2018 Feb 14, 2019	BUY	$10.06 - $14.87 $605,290 - $894,698	60,168 Added 5830.23%	61,200 $807,000
Q3 2018 Nov 14, 2018	BUY	$6.33 - $13.02 $6,532 - $13,436	1,032 New	1,032 $11,000

Others Institutions Holding LFVN

# of Institutions

112

Shares Held

6.76M

Call Options Held

900

Put Options Held

22K

View Full List

About Lifevantage Corp

Ticker LFVN
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 12,560,000
Market Cap $83M
Description
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...

More about LFVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account